RadNet Sets a New Standard: Q2 2026 Results Showcase Unparalleled Growth and Digital Health Dominance
Mark Stolper, Executive Vice President and Chief Financial Officer of RadNet, took center stage during the company's second-quarter 2026 conference call to reveal impressive financial results that far exceeded expectations. Total company revenue skyrocketed by 25% year-over-year to $622.7 million, with adjusted EBITDA following suit, increasing by 22.7% to $99.7 million.
Dr. Howard Berger, President and CEO of RadNet, expressed his satisfaction with the quarter's performance, citing strong demand in advanced imaging procedures such as MRI, CT, and PET CT. These areas saw significant growth, with aggregate MRI volumes increasing by 21%, same-center MRI volumes rising by 4%, and aggregate CT volumes growing by 20.9% while maintaining an 8.6% increase in same-center volume.
The company's focus on expanding capacity through strategic initiatives and capital investments has clearly paid off, as advanced imaging procedural volumes rose 21.2% in aggregate, with a corresponding 9.6% boost in same-center advanced imaging procedures. Furthermore, aggregate PET CT volume saw an impressive 31% jump, while same-center PET CT volumes increased by 8.8%. This favorable mix shift contributed to a 17 basis point improvement in the imaging center segment's adjusted EBITDA margin, which now stands at 16.1%.
RadNet's foray into Digital Health also yielded remarkable results, with incremental sales and licenses of enterprise imaging and AI solutions leading to increased revenue. The company's partnership with health systems has continued to flourish, with 157 out of its 442 centers now part of joint ventures, representing approximately 36% of the total.
These developments demonstrate RadNet's unwavering commitment to innovation and growth. By embracing digital health solutions and expanding its capacity through strategic investments, the company is well-positioned for continued success in the ever-evolving medical imaging landscape."
